AD
Ashok Dattatraya Powar
About Ashok Dattatraya Powar
Data last updated:
Ashok Dattatraya Powar is a Director at Gipsar Speciality Chemicals Private Limited (since 2022) and Director at Gipsa Chempharma Private Limited (since 2026). The companies operate in Agriculture and Chemicals. The largest current company by reported revenue is Gipsar Speciality Chemicals Private Limited at ₹21.7 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gipsar Speciality Chemicals Private Limited U24304MH2022PTC393362 | Director | 12 Nov 2022 | 2022 | ₹21.7 Lakh (FY 2023) | Active |
| Gipsa Chempharma Private Limited U20119MH2026PTC467443 | Director | 04 Feb 2026 | 2026 | Active |
Board colleagues of Ashok Dattatraya Powar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tapaskumar Tinkari Nandi | 06742531 | Gipsar Speciality Chemicals Private Limited | Director |
| Moumita Chakraborty | 11523202 | Gipsa Chempharma Private Limited | Director |
| Shyamal Kumar Chakraborty | 11523203 | Gipsa Chempharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Dattatraya Powar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Dattatraya Powar
Ashok Dattatraya Powar currently holds 2 directorships: Gipsar Speciality Chemicals Private Limited (Director, since 12 Nov 2022, revenue ₹21.7 Lakh (FY 2023)); Gipsa Chempharma Private Limited (Director, since 04 Feb 2026).
Ashok Dattatraya Powar was first appointed on 12 Nov 2022 as Director at Gipsar Speciality Chemicals Private Limited. The most recent appointment on record is 04 Feb 2026 at Gipsa Chempharma Private Limited.
The current boards of Ashok Dattatraya Powar's companies include Tapaskumar Tinkari Nandi (Gipsar Speciality Chemicals Private Limited), Moumita Chakraborty (Gipsa Chempharma Private Limited), Shyamal Kumar Chakraborty (Gipsa Chempharma Private Limited).